Company Performance Metrics
SentryDx develops technologies aimed at improving cancer diagnostics to support treatment decisions. The company focuses on non-invasive testing methods that analyze biomarkers to detect and monitor cancer progression. Its offerings include diagnostic solutions that utilize liquid biopsy techniques, enabling clinicians to access molecular insights
without traditional surgical procedures. It integrates data analytics and laboratory science to enhance the accuracy and accessibility of cancer detection tools. By providing detailed molecular information, the company supports oncologists in making informed decisions regarding therapy selection and disease monitoring. The diagnostic platforms are designed for clinical use, with applications across various cancer types.
